InterX 5002
Commercial- Indications
- Chronic pain, Acute pain, Post-surgical pain
Company intelligence / Profile preview
InterX has developed a proprietary computational platform that enables highly accurate simulations of biochemical interactions. Their polarizable force-field/simulation stack is designed to predict real-world outcomes of chemical processes before they occur. The company collaborates with pharmaceutical partners to accelerate the identification of novel small molecule drugs. Clinical results are not directly applicable as the company provides enabling technology rather than developing its own clinical candidates
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InterX.